Cholera bacteria aren't just battling antibiotics and public health measures—they are also constantly under attack from ...

Hyderabad: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase ...

Vibrio cholerae is the aetiological agent of cholera, a severe diarrhoeal disease that occurs most frequently in epidemic form 1. Cholera has been epidemic in southern Asia for at least 1,000 ...

Bharat Biotech's oral Cholera Vaccine, Hillchol, has successfully completed phase III clinical trials, demonstrating ...

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving ...

In this study, participants were divided into three age groups: adults over 18 years, children aged 5 to under 18 years, and ...

Cholera bacteria engage in microscopic battles with phages, influencing pandemic dynamics and highlighting the role of viral ...